Arteris (NASDAQ:AIP) Receives Buy Rating from Rosenblatt Securities

Rosenblatt Securities restated their buy rating on shares of Arteris (NASDAQ:AIP) in a research report report published on Friday morning, Benzinga reports. The firm currently has a $15.00 price objective on the stock.

Separately, Wedbush reiterated an outperform rating and set a $17.00 price objective on shares of Arteris in a research report on Tuesday, February 20th.

Arteris Trading Up 38.4 %

NASDAQ AIP traded up $2.28 during trading on Friday, reaching $8.21. The company’s stock had a trading volume of 1,105,074 shares, compared to its average volume of 92,112. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.26 and a quick ratio of 1.26. The firm has a fifty day moving average of $6.95 and a 200 day moving average of $6.18. Arteris has a one year low of $3.82 and a one year high of $8.24.

Arteris (NASDAQ:AIP) last announced its earnings results on Tuesday, February 20th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The business had revenue of $12.50 million during the quarter, compared to the consensus estimate of $11.90 million. Arteris had a negative return on equity of 170.93% and a negative net margin of 69.70%. On average, equities research analysts anticipate that Arteris will post -0.9 EPS for the current year.

Insider Activity

In related news, CEO K Charles Janac sold 10,103 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $7.03, for a total transaction of $71,024.09. Following the transaction, the chief executive officer now directly owns 318,644 shares in the company, valued at approximately $2,240,067.32. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other Arteris news, CEO K Charles Janac sold 10,103 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $7.03, for a total value of $71,024.09. Following the completion of the sale, the chief executive officer now owns 318,644 shares in the company, valued at approximately $2,240,067.32. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Nicholas B. Hawkins sold 10,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $6.96, for a total value of $69,600.00. Following the completion of the sale, the chief financial officer now owns 279,727 shares of the company’s stock, valued at approximately $1,946,899.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 80,264 shares of company stock worth $561,883. 36.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Arteris

Institutional investors and hedge funds have recently bought and sold shares of the business. Roubaix Capital LLC lifted its stake in shares of Arteris by 77.1% in the 3rd quarter. Roubaix Capital LLC now owns 254,744 shares of the company’s stock valued at $1,658,000 after purchasing an additional 110,916 shares during the period. Acuitas Investments LLC lifted its stake in shares of Arteris by 34.1% in the 3rd quarter. Acuitas Investments LLC now owns 86,299 shares of the company’s stock valued at $562,000 after purchasing an additional 21,946 shares during the period. Barclays PLC purchased a new position in shares of Arteris in the 3rd quarter valued at approximately $120,000. Ibex Investors LLC purchased a new position in shares of Arteris in the 3rd quarter valued at approximately $99,000. Finally, Acadian Asset Management LLC lifted its stake in shares of Arteris by 120.1% in the 3rd quarter. Acadian Asset Management LLC now owns 368,220 shares of the company’s stock valued at $2,396,000 after purchasing an additional 200,950 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.